NCT05993195View on ClinicalTrials.gov

Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 12, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

March 31, 2024

Conditions
Degenerative SpondylolisthesisLumbar SpondylosisLumbar Spondylolisthesis
Interventions
DEVICE

Conduit Titanium Interbody Graft

The Concorde Bullet Device is compared with Conduit Titanium Interbody Graft for lumber fusion in terms of reoperation rates at 2 years.

DEVICE

Concorde Bullet Device

This traditional device is to compare the clinical results of the new Conduit Titanium Interbody device for lumbar fusion

Trial Locations (1)

01805

Lahey Hospital and Medical Center, Burlington

Sponsors

Lead Sponsor

Lahey Clinic

Collaborators (1)

DePuy Synthes
All Listed Sponsors
collaborator

DePuy Synthes

INDUSTRY

lead

Lahey Clinic

OTHER

NCT05993195 - Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion | Biotech Hunter | Biotech Hunter